INCREASE OF NORADRENALINE RELEASE IN THE HYPOTHALAMUS OF FREELY MOVING RAT BY POSTSYNAPTIC 5-HYDROXYTRYPTAMINE(1A) RECEPTOR ACTIVATION

被引：68

作者：

SUZUKI, M ^{[1
]}

MATSUDA, T ^{[1
]}

ASANO, S ^{[1
]}

SOMBOONTHUM, P ^{[1
]}

TAKUMA, K ^{[1
]}

BABA, A ^{[1
]}

机构：

[1] OSAKA UNIV,FAC PHARMACEUT SCI,DEPT PHARMACOL,SUITA,OSAKA 565,JAPAN

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 1995年 / 115卷 / 04期

关键词：

5-HYDROXYTRYPTAMINE (5-HT); 5-HT1A RECEPTORS; POSTSYNAPTIC; MKC-242; NORADRENALINE (NA) RELEASE; MICRODIALYSIS;

D O I：

10.1111/j.1476-5381.1995.tb14990.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

1 5-Hydroxytryptamine (5-HT) plays a role in the regulation of noradrenergic neurones in the brain, but the precise mechanism of regulation of noradrenaline (NA) release by 5-HT1A receptors has not been defined. The present study describes the effect of a highly potent and selective 5-HT1A receptor agonist, 5-{3-[[(2S)-1,4-benzodioxan-2-ylmethyl]amino]propoxy}-1,3-benzodioxole HCl (MKC-242), on NA release in the hypothalamus using microdialysis in the freely moving rat. 2 Subcutaneous injection of MKC-242 (0.5 mg kg(-1)) increased extracellular levels of NA and its metabolite, 3-methoxy-4-hydroxyphenylglycol, in the hypothalamus and hippocampus. 3 The 5-HT1A receptor agonists, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) (0.2 mg kg(-1)) and buspirone (3 mg kg(-1)) mimicked the effect of MKC-242 in increasing NA release in the hypothalamus. 4 The effects of MKC-242 and 8-OH-DPAT in the hypothalamus were antagonized by pretreatment with WAY100135 (10 mg kg(-1)), a silent 5-HT1A receptor antagonist. 5 Local administration of 8-OH-DPAT (10-100 mu M), citalopram (1 mu M), a 5-HT reuptake inhibitor, and MDL72222 (10 mu M), a 5-HT3 receptor antagonist, into the hypothalamus, had no effect on NA release. 6 Intracerebroventricular injection with 5,7-dihydroxytryptamine caused a marked reduction in brain 5HT content, but the treatment affected neither basal NA levels nor the MKC-242-induced increase in NA release. 7 The effect of MKC-242 in increasing NA release was not attenuated by repeated treatment with the drug (0.5 mg kg(-1), once a day for 2 weeks). 8 The present results suggest that activation of postsynaptic 5-HT1A receptors increases NA release in the hypothalamus.

引用

页码：703 / 711

页数：9

共 44 条

[11]

Done C.J.G., Sharp T., Biochemical evidence for the regulation of central noradrenergic activity by 5‐HT1A and 5‐HT2 receptors: microdialysis studies in the awake and anaesthetized rat, Neuropharmacology, 33, pp. 411-421, (1994)

[12]

Egawa M., Abe M., Tabata R., Saito K.-I., Tobe A., Matsuda T., Baba A., Pharmacological effects of MKC‐242: a novel potential anxiolytic and antidepressant compound with selective 5‐HT1A agonistic profile, Soc. Neurosci. Abstr., 19, (1993)

[13]

Feuerstein T.J., Hertting G., Serotonin (5‐HT) enhances hippocampal noradrenaline (NA) release: Evidence for facilitatory 5‐HT receptors within the CNS, Naunyn-Schmiedeberg's Archives of Pharmacology, 333, pp. 191-197, (1986)

[14]

Fletcher A., Cliffe I.A., Dourish C.T., Silent 5‐HT1A receptor antagonists: utility as research tools and therapeutic agents, Trends Pharmacol. Sci., 14, pp. 441-448, (1993)

[15]

Fuller R., Perry K.W., Effects of buspirone and its metabolite, 1‐(2‐pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats, J. Pharmacol. Exp. Ther., 2A8, pp. 50-56, (1989)

[16]

Gartside S.E., Cowen P.J., Hjorth S., Effects of MDL 73005EF on central pre‐ and postsynaptic 5‐HT1A receptor function in the rat in vivo, Eur. J. Pharmacol., 191, pp. 291-400, (1990)

[17]

Gobbi M., Frittoli E., Mennini T., Antagonist properties of 1‐(2‐pyrimidinyl)‐piperazine at presynaptic α2‐adrenoceptors in the rat brain, Eur. J. Pharmacol., 180, pp. 183-186, (1990)

[18]

Godbout R., Chaput Y., Blier P., De Montigny C., Tandspirone and its metahbolite, 1‐(2‐pyrimidinyl)‐piperazine. I. Effects of acute and long‐term administration of tandospirone on serotonin transmission, Neuropharmacology, 30, pp. 679-690, (1991)

[19]

Gorea E., Ardrien J., Serotonergic regulation of noradrenergic coerulean neurons: electrophysiological evidence for the involvement of 5‐HT2 receptors, Eur. J. Pharmacol., 154, pp. 285-291, (1988)

[20]

Gorea E., Davenne D., Lanfumey L., Chastanet M., Adrein J., Regulation of noradrenergic coerulean neuronal firing mediated by 5‐HT2 receptors: involvement of the prepositus hypoglossal nucleus, Neuropharmacology, 30, pp. 1309-1318, (1991)

← 1 2 3 4 5 →